eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | uveitis |
| Comorbidity | C0004943|behcet\'s disease |
| Sentences | 19 |
| PubMedID- 24424168 | Posterior uveitis is associated with behcet's disease and hla-b51. |
| PubMedID- 22546542 | Inhibition of th17 differentiation by anti-tnf-alpha therapy in uveitis patients with behcet's disease. |
| PubMedID- 23316652 | uveitis in behcet's disease (bd) is an important cause of vision loss through recurrent ocular inflammatory attacks. |
| PubMedID- 20029140 | [6] its efficacy has been proven beyond doubt in the treatment of systemic diseases such as rheumatoid arthritis (ra), juvenile idiopathic arthritis (jia), as well as endogenous, non-infectious refractory uveitis associated with behcet's disease and sarcoidosis. |
| PubMedID- 24199188 | Table 8 shows treatment of uveitis in behcet's disease. |
| PubMedID- 20542984 | Timing of recurrent uveitis in patients with behcet's disease receiving infliximab treatment. |
| PubMedID- 24835134 | behcet's disease was a representative of vision loss uveitis because behcet's patient usually had treatment resistance of conventional treatment, such as colchicine and cyclosporine. |
| PubMedID- 23470459 | Several open prospective studies have shown the effectiveness of ifn-alpha (78 to 98% complete remission) for the treatment of severe uveitis in behcet's disease. |
| PubMedID- 24939422 | Changes in subfoveal choroidal thickness associated with uveitis activity in patients with behcet's disease. |
| PubMedID- 19816689 | Infliximab has demonstrated remarkable effects on controlling uveitis in patients with behcet's disease (bd). |
| PubMedID- 22220161 | Oct-based retinal thickness analysis in the eyes of behcet's disease patients with uveitis revealed a correlation between retinal thickness decrease and an increase in the duration of uveitis [7]. |
| PubMedID- 23630362 | Role of il-22- and tnf-alpha-producing th22 cells in uveitis patients with behcet's disease. |
| PubMedID- 24994946 | The aim of the present study was to determine the serum cytokine profile and levels of high sensitivity c-reactive protein (hscrp) in patients with uveitis associated with behcet's disease (bd) and to compare them with those obtained from healthy control subjects. |
| PubMedID- 21958178 | The earliest was interferon-alpha, and a multitude of reports have described its benefits for the uveitis associated with behcet's disease. |
| PubMedID- 23090423 | Purpose: to report a case of psoriasis triggered by anti-tumor necrosis factor-alpha (tnf-alpha) therapy in a uveitis patient with behcet's disease. |
| PubMedID- 24683491 | Specifically, ivta has been effectively used to treat uveitis associated with behcet's disease [83–85], vkh syndrome [86], serpinginous choroiditis [87], and sympathetic ophthalmia [88–91]. |
| PubMedID- 20135752 | The evaluated parameters were similar in behcet's disease patients with and without uveitis, and pathergy-positive and pathergy-negative groups. |
| PubMedID- 24492505 | Most of the biologics mainly infliximab have been proven to be very effective in the treatment of severe refractory uveitis especially in patients with behcet's disease. |
| PubMedID- 22750994 | Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in behcet's disease. |
Page: 1